Delivery Order SPE2DB22D2206-SPE2DB24FHS90
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract, valued at $23,824.28, has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract, valued at $23,824.28, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on July 2, 2024, with a completion date of July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award, valued at $29,780.35, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TECVAYLI 30 MG/3 ML VIAL 3ML, a pharmaceutical product. The contract has a ceiling value of $3,479.73 and is a Firm Fixed Price Delivery Order with a period of performance through June 20, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, with a ceiling value of $7,352.94. The contract is a Firm Fixed Price arrangement with a May 10, 2024 completion date. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to federal agencies, including the Department of Defense (DoD) and Veterans Affairs (VA). The company holds an Indefinite Delivery Contract...
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $170,743.97 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a firm fixed-price delivery order with an ultimate completion date of April 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
- The U.S. government has awarded a $1,855.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract, with a completion date of June 27, 2024, is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA through...
- The U.S. government has awarded a $14,406.32 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which does not have a set-aside designation, is to provide pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. Amerisourcebergen, a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The $4,673.32 firm fixed-price contract is for the supply of pharmaceutical and medical products to DLA and other government agencies. Amerisourcebergen is a major supplier of medications, medical devices, and supplies to the Department of Defense and Veterans Affairs healthcare systems. The company holds a larger...
- The U.S. government's Defense Logistics Agency (DLA) has awarded a $17,401.91 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FHS90Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $23,824.28 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, with a period of performance through July 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, particularly the Department of Defense and Veterans Affairs healthcare systems. The company holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, as well as a smaller IDC with the Department of Justice Federal Bureau of Investigation valued up to $750,000 through May 2024. These contracts enable the government agencies to efficiently procure essential medical commodities. The current award to Amerisourcebergen was made on a full and open competition basis without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.8k | 6/12/24 |